YiNuo

Tianjin YiNuo is a Chinese subsidiary of Immunophotonics founded in 2012. The company’s objective is to develop inCVAX for the Chinese market, utilizing local partnerships and collaborations. Tianjin YiNuo is currently supporting critical toxicology and pharmacokinetic studies designed to fulfill global regulatory requirements.